# Menyanthes trifoliata (Bogbean)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/menyanthes-trifoliata
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Herb
**Also Known As:** Menyanthes trifoliata, Bogbean, Buckbean, Marsh trefoil, Water trefoil, Bog myrtle, Bitter trefoil, European bogbean, Bog hop

## Overview

Menyanthes trifoliata, commonly called bogbean, is a wetland herb containing bitter iridoid glycosides (primarily menyanthine and loganin) alongside phenolic acids and flavonoids. These bitter compounds stimulate vagal nerve reflexes in the gastrointestinal tract, increasing [digestive enzyme](/ingredients/condition/gut-health) secretion and bile flow to support appetite and digestion.

## Health Benefits

• May stimulate appetite and digestive secretions - Traditional use documented in European pharmacopoeias, though no clinical trials available
• Potential DNA-protective effects - Preclinical studies show phenolic compounds protect against DNA damage in vitro
• May support [inflammatory](/ingredients/condition/inflammation) balance - Root extracts inhibit TNF-α and IFN-γ production in laboratory studies
• Traditional bitter tonic for dyspepsia - Used in multi-herb formulas across Austria, Germany, and other European countries
• Possible [antimicrobial](/ingredients/condition/immune-support) activity - Phenolic acids and triterpenes show antimicrobial effects in preliminary research

## Mechanism of Action

The iridoid glycosides menyanthine and loganin activate bitter taste receptors (TAS2Rs) on the tongue and gastric mucosa, triggering reflex secretion of hydrochloric acid, pepsin, and bile acids to enhance digestive capacity. Phenolic compounds including chlorogenic acid and caffeic acid inhibit cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, modulating eicosanoid synthesis and reducing pro-[inflammatory](/ingredients/condition/inflammation) signaling. Additionally, in vitro evidence suggests these same polyphenols scavenge [reactive oxygen species](/ingredients/condition/antioxidant) and activate Nrf2-mediated antioxidant response elements, offering cytoprotective and DNA-stabilizing effects.

## Clinical Summary

No published randomized controlled trials have evaluated Menyanthes trifoliata in human subjects, leaving its clinical evidence base limited to traditional pharmacopoeial documentation and preclinical data. Several in vitro studies have demonstrated that bogbean phenolic extracts reduce oxidative DNA strand breaks in cultured cells, though these findings have not been translated to human models. Animal models suggest bitter glycosides increase gastric secretion measurably, consistent with its longstanding listing in the German Commission E monographs for appetite loss and dyspeptic complaints. Overall, evidence strength is low-to-preliminary, and all benefit claims should be interpreted as traditional use supported by mechanistic plausibility rather than clinical proof.

## Nutritional Profile

Menyanthes trifoliata is a non-nutritive medicinal herb with negligible macronutrient contribution at typical therapeutic doses. Key bioactive compounds include: Iridoid glycosides (primary bitter principles) — loganin, sweroside, and foliamenthin at approximately 0.5–1.2% dry weight of leaf material, responsible for bitter taste index values exceeding 1:10,000 dilution. Secoiridoids — menthiafolin and dihydrofoliamenthin present at trace concentrations (estimated 0.1–0.3% dry weight). Flavonoids — rutin, hyperoside, and kaempferol glycosides collectively estimated at 1–3% dry weight; these phenolic compounds are associated with the observed in vitro DNA-protective activity. Phenolic acids — chlorogenic acid and caffeic acid derivatives present at approximately 0.2–0.8% dry weight. Alkaloids — gentianine and traces of other pyridine alkaloids at very low concentrations (<0.1% dry weight). Tannins — condensed tannins contributing mild astringency, estimated 3–5% dry weight in leaves. Triterpenes — betulinic acid derivatives and stigmasterol in small quantities. Coumarin derivatives — scopoletin identified at trace levels. Mineral content is modest; leaves contain measurable manganese, iron, and potassium, though concentrations vary significantly by growing location and are not standardized. Dietary fiber is present in whole plant preparations but not therapeutically relevant. Bioavailability notes: Iridoid glycosides undergo partial hydrolysis in the gut; bitter compounds exert primary effects via oropharyngeal bitter receptors (TAS2Rs) before absorption, meaning bioavailability of intact glycosides for systemic effects is limited. Flavonoid absorption is enhanced by [gut microbiome](/ingredients/condition/gut-health) deglycosylation to aglycone forms.

## Dosage & Preparation

Traditional pharmacopoeial formulas include bogbean leaf at 15-25 parts per 100 in multi-herb mixtures, with Austrian dyspepsia products containing 53 mg equivalent per 100 ml. No clinically studied dosage ranges exist for standardized extracts or powders. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bogbean is generally considered safe at traditional doses (1–2 g dried herb or 2–3 mL tincture daily), but its bitter principles can cause nausea, vomiting, or diarrhea in excessive amounts. Due to its potential to stimulate gastric acid secretion, it is contraindicated in individuals with peptic ulcers, gastroesophageal reflux disease (GERD), or active gastritis. Theoretical interactions exist with anticoagulant medications such as warfarin, as some iridoid-containing plants may modestly affect platelet aggregation, though direct evidence for bogbean specifically is lacking. Safety during pregnancy and breastfeeding has not been established, and use should be avoided in these populations until more data are available.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Menyanthes trifoliata in the available research. Traditional use is documented in European pharmacopoeias and multi-component formulas for dyspepsia, but these lack specific trial data on efficacy or outcomes.

## Historical & Cultural Context

Bogbean has been used for centuries in European traditional medicine as a bitter tonic, documented in multiple pharmacopoeias including Pharmacopoea Polonica (1937-2002) and Russian Pharmacopoeia. Historical uses include treatment of fevers, skin disorders, scurvy, and as an appetite stimulant, typically in bitter tinctures like Tinctura Amara.

## Synergistic Combinations

Celery seed, White willow, Gentian root, Dandelion, Artichoke leaf

## Frequently Asked Questions

### What is bogbean used for traditionally?

Bogbean has been used in European herbal medicine for centuries primarily to stimulate appetite and relieve dyspeptic complaints such as bloating and sluggish digestion. It is listed in the German Commission E monographs as an approved herb for these indications, based on documented traditional use and its known bitter glycoside content. Secondary traditional applications include use as a mild anti-inflammatory remedy for rheumatic conditions.

### What are the active compounds in Menyanthes trifoliata?

The primary bioactive compounds in bogbean are iridoid glycosides, particularly menyanthine, foliamenthin, and loganin, which are responsible for its intensely bitter taste and digestive-stimulating effects. The plant also contains phenolic acids (chlorogenic acid, caffeic acid), flavonoids (rutin, hyperoside), and triterpene saponins that contribute to its antioxidant and anti-inflammatory properties. Alkaloids and coumarins are present in minor quantities and may add to its pharmacological profile.

### Does bogbean have any anti-inflammatory effects?

Preclinical research indicates that bogbean extracts inhibit COX and LOX enzyme pathways, which are central mediators of the inflammatory cascade involved in prostaglandin and leukotriene synthesis. Phenolic constituents such as chlorogenic acid have demonstrated dose-dependent anti-inflammatory activity in cell culture models, reducing markers like IL-6 and TNF-alpha. However, no clinical trials have confirmed these effects in humans, so anti-inflammatory claims remain mechanistically plausible but unproven at the clinical level.

### What is the recommended dosage of bogbean?

Traditional European herbal dosing guidelines recommend 1–2 grams of dried bogbean leaf as a tea infusion taken 2–3 times daily before meals to stimulate appetite and digestion. Tincture preparations (1:5 in 25% ethanol) are typically dosed at 1–3 mL taken three times daily. Doses above these ranges are associated with gastrointestinal irritation including nausea and loose stools, and no standardized extract dosing exists due to the absence of clinical trials.

### Is bogbean safe to take with blood thinners?

There is a theoretical concern that bogbean may interact with anticoagulant or antiplatelet medications such as warfarin, aspirin, or clopidogrel, because some iridoid-containing herbs have shown mild effects on platelet function in preclinical settings. Direct pharmacokinetic interaction studies for bogbean specifically do not exist in the published literature, making the true interaction risk unknown. Until safety data are available, individuals taking blood-thinning medications should consult a healthcare provider before using bogbean supplements.

### Is bogbean safe during pregnancy and breastfeeding?

Bogbean should be avoided during pregnancy and breastfeeding due to insufficient safety data and its traditional use as a bitter digestive stimulant, which may affect hormone levels or uterine function. No clinical studies have evaluated its safety in pregnant or nursing women, making caution the appropriate approach until more evidence is available.

### Does bogbean interact with common medications like metformin or diabetes drugs?

Bogbean may have mild effects on blood sugar metabolism based on traditional use, though no formal drug interaction studies exist. If you take diabetes medications or blood sugar regulators, consult your healthcare provider before adding bogbean, as combining them could theoretically potentiate glucose-lowering effects.

### What is the most bioavailable form of bogbean—dried herb, extract, or tincture?

Liquid extracts and tinctures are traditionally considered most bioavailable for bogbean's bitter compounds and iridoid glycosides because alcohol extraction enhances absorption of these water-soluble and lipid-soluble constituents. Dried herbal preparations require decoction (simmering) to fully release active compounds, whereas standardized extracts provide consistent potency, though no comparative bioavailability studies have directly tested these forms.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*